Research Article
The Role of MIF-173G/C Gene Polymorphism in the Susceptibility of Autoimmune Diseases
Table 1
Characteristics of the included studies.
| First author | Year | Disease | Country | Area | Method | Case | Control | | GG | GC | CC | GG | GC | CC |
| Alfonso | 2007 | RA | Mexico | North America | PCR-RFLP | 431 | 157 | 18 | 681 | 188 | 18 | 0.24 | Assis (1) | 2014 | AIH | America | Europe | ELISA | 31 | 13 | 1 | 219 | 63 | 4 | 0.83 | Assis (2) | 2014 | PBC | America | Europe | ELISA | 215 | 82 | 7 | 219 | 63 | 4 | 0.83 | Fei (1) | 2008 | UC | China | Asia | PCR-RFLP | 44 | 27 | 13 | 79 | 55 | 8 | 0.7 | Fei (2) | 2008 | CD | China | Asia | PCR-RFLP | 8 | 5 | 2 | 79 | 55 | 8 | 0.7 | Nunez | 2007 | CD | Spain | Europe | NA | 372 | 149 | 10 | 681 | 188 | 18 | 0.24 | Çevik | 2016 | AS | Turkey | Europe | RFLP | 116 | 42 | 3 | 136 | 49 | 9 | 0.11 | Zhan | 2013 | VKH | China | Asia | PCR-RFLP | 360 | 226 | 14 | 417 | 167 | 16 | 0.88 | David (1) | 2016 | AIH | Japan | Asia | ELISA | 36 | 14 | 2 | 18 | 12 | 0 | 0.17 | David (2) | 2016 | AIH | America | Europe | ELISA | 37 | 15 | 1 | 18 | 12 | 0 | 0.17 | Sanchez | 2006 | SLE | Spain | Europe | PCR-RFLP | 503 | 175 | 33 | 570 | 171 | 14 | 0.78 | Wang | 2013 | AOSD | China | Asia | PCR-RFLP | 69 | 26 | 5 | 157 | 42 | 1 | 0.31 | Wu | 2009 | Ps | China | Asia | PCR-RFLP | 137 | 94 | 9 | 163 | 95 | 8 | 0.8 | Jung | 2016 | AD | Korea | Asian | PCR-RFLP | 117 | 51 | 10 | 61 | 18 | 1 | 0.18 | Karolina (1) | 2011 | UC | Poland | Europe | PCR-RFLP | 38 | 19 | 1 | 99 | 23 | 1 | 0.79 | Karolina (2) | 2011 | CD | Poland | Europe | PCR-RFLP | 28 | 12 | 1 | 99 | 23 | 1 | 0.79 | Larissa | 2006 | RA | Germany | Europe | PCR | 90 | 24 | 5 | 160 | 59 | 6 | 0.84 | Ma | 2013 | AD | China | Asia | NA | 93 | 65 | 15 | 136 | 75 | 7 | 0.39 | M.A. | 2013 | RA | Mexico | North America | PCR-RFLP | 43 | 49 | 8 | 53 | 42 | 5 | 0.36 | Wu | 2006 | SD | America | Europe | ELISA | 105 | 47 | 7 | 149 | 72 | 6 | 0.44 | Timothy | 2005 | RA | Holland | Europe | PCR | 188 | 71 | 11 | 198 | 69 | 10 | 0.20 | Zheng | 2012 | BD | China | Asia | PCR-RFLP | 359 | 212 | 29 | 417 | 167 | 16 | 0.88 | Hao (1) | 2015 | HSPN | China | Asia | PCR-RFLP | 3 | 8 | 20 | 8 | 15 | 7 | 1.00 | Hao (2) | 2015 | HSPN | China | Asia | PCR-RFLP | 5 | 11 | 24 | 10 | 14 | 6 | 0.79 | Ruan | 2014 | UC | China | Asia | NA | 99 | 61 | 5 | 124 | 69 | 6 | 0.33 | Xie | 2007 | RA | China | Asia | PCR | 28 | 10 | 5 | 19 | 8 | 3 | 0.16 | Zhang (1) | 2014 | HSP | China | Asia | PCR-RFLP | 2 | 7 | 16 | 5 | 13 | 7 | 0.82 | Zhang (2) | 2014 | HSP | China | Asia | PCR-RFLP | 2 | 8 | 15 | 10 | 14 | 6 | 0.79 | Zhuang | 2014 | PG | China | Asia | PCR-RFLP | 18 | 9 | 3 | 190 | 114 | 9 | 0.09 |
|
|
RA: rheumatoid arthritis; AIH: autoimmune hepatitis; PBC: primary biliary cirrhosis; UC: ulcerative colitis; CD: Crohn’s disease; AS: ankylosing spondylitis; VKH: Vogt-Koyanagi-Harada syndrome; SLE: systemic lupus erythematosus; AOSD: adult Still disease; Ps: psoriasis; AD: atopic dermatitis; SD: scleroderma; BD: Behcet’s disease; HSPN: Henoch-Schonlein purpura nephritis; HSP: Henoch-Schonlein purpura; PG: primary gout; PCR-RFLP: Polymerase Chain Reaction-Restriction Fragment Length Polymorphism; PCR: Polymerase Chain Reaction; NA: not available.
|